Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.

Bookmark and Share
Published: 6 Jun 2016
Views: 1492
Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Dr Lemieux speaks with ecancertv at ASCO 2016 with results from MA.17R, a randomised trial in which doubling the duration of letrozole treatment for postmenopausal women with early stage breast cancer resulted in significantly improved survival.

She reports on the increased rate of progression-free survival, and patient outcomes beyond relapse rate.

For more details from this study, you can watch the press announcement from Dr Lemieux here, or from co-author Dr Paul Goss here. Alternatively, the news story is available to read here.